Organon Forecasts 2024 Full Year Revenues Of $6.2B-$6.5B Versus Consensus Of $6.40B, With Adjusted EBITDA Margin Of 31.0%-33.0%
Portfolio Pulse from Benzinga Newsdesk
Organon forecasts its full year revenues for 2024 to be between $6.2 billion and $6.5 billion, aligning closely with the consensus estimate of $6.40 billion. Additionally, the company anticipates an adjusted EBITDA margin of 31.0% to 33.0%.
February 15, 2024 | 12:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Organon forecasts 2024 revenues of $6.2B-$6.5B, in line with consensus estimates of $6.40B, and expects an adjusted EBITDA margin of 31.0%-33.0%.
Organon's revenue forecast for 2024 is closely aligned with market consensus, indicating a positive outlook and potentially boosting investor confidence. The anticipated adjusted EBITDA margin further underscores the company's profitability expectations, likely contributing to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100